Our VP of People and organisational development Denise Emsden shares how intentional culture design fuels global collaboration + innovation.
🎥 Watch: https://t.co/ZQQdumd00O
#Leadership#InnovationCulture#Biotech
Save the Date!
Join Dr. Manjunath Hegde of Iontas/FairJourney Biologics for a live webinar on next-gen antibody discovery using Cyto-Mine® Chroma & FACSDiscover�� S8
🗓️ September 23, 2025
⏰ 16:00 BST / 17:00 CEST / 11:00 EDT
#AntibodyDiscovery #Biotech #Webinar
At Sphere Bio, we’re proud to offer Cyto-Mine® Chroma - a single-cell analysis platform using picodroplet tech to screen millions of viable cells in a day.
Fast. Flexible. Multiplex-capable.
#CytoMineChroma#SphereBio#CellLineDev#CGT
📢 Biopharma Conclave 2025 lands in Hyderabad this Aug 19–20!
Two focused tracks - Biosimilars & Biologics + Cell & Gene Therapy - set the stage for breakthrough thinking and solutions.
https://t.co/MXcjEDT9em
#SphereBio#BiopharmaConclave2025#CGT
We’ve grown - and so has our brand.
Sphere Fluidics is now Sphere Bio to reflect our role in powering single-cell discovery at scale.
Full story: https://t.co/n1IR1GCD8G
#SphereBio#LifeSciences#Rebrand#BiotechTools
Single-cell analysis has become a core engine of biopharma innovation. We’re helping teams go faster with integrated, automated, high-throughput workflows.
👉 https://t.co/FgQkbhDh0f
#SingleCellAnalysis#SphereBio
Cell therapies like CAR T cells are revolutionizing cancer treatment by harnessing immune precision. Learn how new strategies may improve efficacy and safety.
👉 https://t.co/8dbEd8Lrt0
#CAR-T #CellTherapy
We’re unlocking the next frontier in in vivo gene therapy.
Watch our on-demand webinar with Dr. Luke Zhou, CEO of Santo Therapeutics, to explore how microfluidics is revolutionizing CGT.
🎥 Watch now: https://t.co/hw7PaGzweB
#Microfluidics#CellTherapy
Less plastic. Less energy. More science. ♻️
Learn how Sphere Bio’s platforms outperform and reduce environmental impact.
📘 Interview with Kieran Priest: https://t.co/fistiT1UO0
#SustainableBiotech#GreenLabs#SingleCellTech
CAR-T validation just got faster.
Discover how picodroplets enable high-throughput screening of engineered T cells - function + phenotype in one step.
📘 New eBook: https://t.co/rOnqNsxivE
#CART#CellTherapy#SingleCell#Biotech#Microfluidics
Need monoclonality, cell screening, and scalability in one platform?
Cyto-Mine® Chroma integrates into your workflow and grows with your research.
👉 https://t.co/XFBeiOPcMs
#BiotechTools#CytoMineChroma#Monoclonality
Sphere Bio is now Sphere Fluidics — a name that reflects our expanded portfolio and commitment to accelerating therapeutic discovery through ultra-high-throughput single-cell tools.
🔗 https://t.co/n1IR1GCD8G
#Biotech#SingleCell#SphereBio
Single-cell analysis has become a core engine of biopharma innovation. We’re helping teams go faster with integrated, automated, high-throughput workflows.
👉 https://t.co/qAVfSKNh50
#SingleCellAnalysis#SphereBio
Cell therapies like CAR T cells are revolutionizing cancer treatment by harnessing immune precision.
Learn how new strategies may improve efficacy and safety.
👉 https://t.co/8dbEd8Lrt0
#CAR_T#CellTherapy
⚡ Millions of single cells. One day. Real insights.
Cyto-Mine® Chroma delivers high-throughput functional screening with precision and speed.
👉 https://t.co/XFBeiOPcMs
#SingleCell#Biopharma#CytoMineChroma